BioSquare V2.0

Fact

Effective partnering opportunities lead to successful ventures.

Fact

Biotech, medtech, nanotech and in silico sectors are coming together as never before; we are witnessing the birth of bioconvergence.

Fact

The new BioSquare is the premiere bioconvergence partnering meeting for mature companies, high potential start-ups or willing investors working in the bioconvergence universe worldwide.

Fact

Expect an event that adds to your bottom line.

Did we mention it’s going to be the most enjoyable BioSquare ever?

BioSquare V2.0 Highlights

BioSquare has set high goals. It has also retained key fundamentals.

Make valuable business connections The one-to-one paradigm lives on but with major changes. You will meet people in far more comfort, with greater privacy and with superior presentation options.

New BioSquare partnering software No modern partnering event can function without a one-to-one partnering platform. A superior event needs a flawless application that is easy to use and flexible. Our goal is to continue software development year to year; we consider keeping our partnering application current an essential task. Those who use the application to its fullest extent, prior to, during and after the event will establish high value business connections. More

Sponsorship opportunities revisited Sponsorship and visibility opportunities are still on the menu but BioSquare is streamlining them. Visibility has been well studied to maximise impact — we want attendees to see your message, retain your message and act on your message. More

Presentations Selected presentations of portfolio strategies have been, and are still, part of the programme with the same heightened obsession to maximise impact. In 2010, BioSquare will place particular emphasis on promising young talents. More

Panels and Workshops BioSquare 2010’s conference track is entirely devoted to business development and innovation with few select keynote speeches and exciting speakers challenged by professional moderators. More

Who should attend?

BioSquare targets decision-makers that are ready to deal.

Historically, 46% of BioSquare attendees are President/CEO/Partner level, 21% are Senior VP/Director level and the remainder is academia, media and middle management. Over the last three BioSquare events the trend has been leaning towards higher-level attendees (President/CEO/Partner).

Sectorially, those that have regularly attended BioSquare are bio-technology companies, medical-technology companies, nano-technology companies, diagnostics, pharmaceutical, technology licensing offices, major research institutions, high potential start-ups and investment companies and individuals — without planning on it, we were a bioconvergence event all along.

Clearly, all life sciences players are welcome, but our focus is on companies that are sufficiently mature in their development to warrant an imminent investment or partnership.